According to our present observations, p53-deficient pancreatic cancer AsPC-1 cells exhibited a much more higher resistance to GEM as compared with p53-proficient pancreatic cancer SW1990 cells. This evidence concerns the gene TP53 and familial pancreatic carcinoma.